An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam
Clinical trial NCT00761774 · COMPLETED
Trial details
- NCT number
- NCT00761774
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2017-03-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.